Qube Research & Technologies (QRT)
SLS icon

Qube Research & Technologies (QRT)’s SELLAS Life Sciences SLS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$2 – 4033
2024
Q2 		$2 Hold
2
– – ﹤0.01% 3695
2024
Q1 		$2 Hold
2
– – ﹤0.01% 4370
2023
Q4 		$2 Hold
2
– – ﹤0.01% 4246
2023
Q3 		$3 Buy
+2
New +$3 ﹤0.01% 3994

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SLS Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of SELLAS Life Sciences (SLS) in Q3 2024, closing a stake of 2 shares — an estimated $2 sold.

Qube Research & Technologies (QRT) first reported a position in SLS in Q3 2023 and held it in 4 quarters. The position peaked at $3 in Q3 2023. 33 funds tracked by Wall St. Rank hold SLS as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining SELLAS Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2 SELLAS Life Sciences shares in Q3 2024, an estimated $2.
  • Qube Research & Technologies (QRT) first reported a position in SELLAS Life Sciences in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s SELLAS Life Sciences position peaked at $3 in Q3 2023.
  • 33 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.